SHAREHOLDER DEADLINE NOTICE: Scott+Scott Attorneys at Law LLP Reminds Investors that a Securities Class Action Has Been Filed Against Dentsply Sirona, Inc. (NASDAQ: XRAY)

Lead Plaintiff Deadline is January 27, 2025

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, notifies investors that the deadline to move for lead plaintiff in a securities class action lawsuit against Dentsply Sirona, Inc. (NASDAQ: XRAY) (“Dentsply” or the “Company”) and certain other defendants (collectively, “Defendants”) is January 27, 2025.

CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS CLASS ACTION

The action, which was filed in the U.S. District Court for the Southern District of New York, asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) on behalf of a Class consisting of all persons who purchased Dentsply common stock between December 1, 2022, and November 6, 2024, inclusive (the “Class Period”), and who were damaged thereby (the “Class”).

According to the Complaint, during the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose material adverse facts about the Company’s business operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company’s Byte aligners caused severe patient injuries for years; (2) the Company failed to report the injuries to the U.S. Food and Drugs Administration; and (3) the Company had greatly overvalued the financial contribution of the Byte aligners, among other things.

When the truth emerged, according to the Complaint, Dentsply’s share price fell $6.72 per share, or more than 28%, to close at $17.26 per share on November 7, 2024, thereby injuring investors.

Lead Plaintiff Deadline

The Lead Plaintiff deadline in this action is January 27, 2025. Any member of the proposed Class may seek to serve as Lead Plaintiff through counsel of their choice, or may choose to do nothing and remain a member of the proposed Class.

What You Can Do

If you purchased Dentsply common stock during the Class Period, and suffered damages, realized or unrealized, you are encouraged to contact Scott+Scott attorney Nicholas Bruno at [phone], or [e-mail], for more information.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, Virginia, California, and Ohio.

Attorney Advertising